Latest News

Epilepsy community seeks redefinition of bioequivalence from FDA

For several years, epilepsy practitioners have questioned the U.S. Food and Drug Administration?s (FDA) definition of bioequivalence as it applies to narrow therapeutic index (NTI) drugs, such as those used for epilepsy. In response to these concerns, the FDA has sponsored 3 studies of antiepileptic drugs and also convened an advisory board to help determine which drugs are NTI.
View full story

Post your comment.


  • Cognitive-behavioral stress management in breast cancer

  • Underage drinkers' brand preferences vary by race, age, study finds

  • Watching eyes prevent littering

  • 45 percent increase in mortality from law enforcement from 1999 to 2013, report shows

  • Magnesium ions show promise in slowing progression of Alzheimer's disease in mice

  • why and when straight women form close friendships with gay men

  • First language wires brain for later language-learning

  • Unfriending on Facebook more likely from politically active users

  • Decline in cognitive ability leads to fear of upfront costs

  • Early progress reported in designing drugs that target 'disordered' proteins